Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.

Na, Yanqun; Ye, Zhangqun; Zhang, Shanzhong

Na, Yanqun; Ye, Zhangqun; Zhang, Shanzhong.

Afiliação

Na Y; Department of Urology, Beijing Shougang Hospital, Affiliated Hospital of Beijing University, Beijing, China.
Ye Z; Department of Urology, Tongji Hospital, Affiliated Hospital of Huazhong University of Science and Technology, Hubei, China.
Zhang S; Medical Department, GlaxoSmithKline China, 168 Middle Tibet Road, 6th Floor, Huangpu District, Shanghai, 200001, China. shanzhong.s.zhang@gsk.com.

Clin Drug Investig ; 32(1): 29-39, 2012 Jan.

Article em En | MEDLINE | ID: mdl-27933597

Assuntos

Inibidores de 5-alfa Redutase/uso terapêutico; Dutasterida/uso terapêutico; Hiperplasia Prostática/tratamento farmacológico; Idoso; Método Duplo-Cego; Dutasterida/efeitos adversos; Humanos; Masculino; Pessoa de Meia-Idade

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links